BrainStorm advances ALS cell therapy with FDA-backed trial design
CGTLive - 10-Jul-2024New phase 3b study aims to resolve manufacturing challenges and support regulatory approval
Join the club for FREE to access the whole archive and other member benefits.
New phase 3b study aims to resolve manufacturing challenges and support regulatory approval
Experts discuss on the ethics and feasibility of body transplants in the near future
This could potentially revolutionize treatment for severe conditions
Specialized protocol aims to address early-stage ALS and advance regulatory approval efforts
Light-driven artificial nerve could one day be used for medical devices or implants to cure diseases
No resources found!
No blog posts found!